BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 32070049)

  • 1. CharXgen-Activated Bamboo Charcoal Encapsulated in Sodium Alginate Microsphere as the Absorbent of Uremic Toxins to Retard Kidney Function Deterioration.
    Lin CJ; Sun CY; Wu CJ; Wu CC; Wu V; Lin FH
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32070049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
    Bennis Y; Cluet Y; Titeca-Beauport D; El Esper N; Ureña P; Bodeau S; Combe C; Dussol B; Fouque D; Choukroun G; Liabeuf S
    Toxins (Basel); 2019 May; 11(5):. PubMed ID: 31109001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120.
    Liu WC; Tomino Y; Lu KC
    Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30208594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Charcoal Adsorbents Attenuate Neointima Formation of Arteriovenous Fistulas.
    Shih YC; Wu CC; Wang SC; Liou JY; Huang PH; Tarng DC
    Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32276394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uremia Impacts VE-Cadherin and ZO-1 Expression in Human Endothelial Cell-to-Cell Junctions.
    Maciel RAP; Cunha RS; Busato V; Franco CRC; Gregório PC; Dolenga CJR; Nakao LS; Massy ZA; Boullier A; Pecoits-Filho R; Stinghen AEM
    Toxins (Basel); 2018 Oct; 10(10):. PubMed ID: 30301260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uremic Toxic Blood-Brain Barrier Disruption Mediated by AhR Activation Leads to Cognitive Impairment during Experimental Renal Dysfunction.
    Bobot M; Thomas L; Moyon A; Fernandez S; McKay N; Balasse L; Garrigue P; Brige P; Chopinet S; Poitevin S; Cérini C; Brunet P; Dignat-George F; Burtey S; Guillet B; Hache G
    J Am Soc Nephrol; 2020 Jul; 31(7):1509-1521. PubMed ID: 32527975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Targeting of Aristolochic Acid Induced Uremic Toxin Retention, SMAD 2/3 and JNK/ERK Pathways in Tubulointerstitial Fibrosis: Nephroprotective Role of Propolis in Chronic Kidney Disease.
    Chang JF; Hsieh CY; Lu KC; Chen YW; Liang SS; Lin CC; Hung CF; Liou JC; Wu MS
    Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32498221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AST-120 to Target Protein-Bound Uremic Toxins Improves Cardiac Output and Kidney Oxygenation in Experimental Chronic Kidney Disease.
    Sivertsson E; Ceder S; Nangaku M; Hansell P; Nordquist L; Palm F
    Kidney Blood Press Res; 2023; 48(1):114-123. PubMed ID: 36791683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous Reduction of Protein-Bound Uraemic Toxins with Improved Oxidative Stress by Using the Oral Charcoal Adsorbent AST-120 in Haemodialysis Patients.
    Yamamoto S; Kazama JJ; Omori K; Matsuo K; Takahashi Y; Kawamura K; Matsuto T; Watanabe H; Maruyama T; Narita I
    Sci Rep; 2015 Sep; 5():14381. PubMed ID: 26395517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial glycocalyx damage in kidney disease correlates with uraemic toxins and endothelial dysfunction.
    Liew H; Roberts MA; Pope A; McMahon LP
    BMC Nephrol; 2021 Jan; 22(1):21. PubMed ID: 33423673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the Oral Adsorbent AST-120 on Organ-Specific Accumulation of Uremic Toxins: LC-MS/MS and MS Imaging Techniques.
    Sato E; Saigusa D; Mishima E; Uchida T; Miura D; Morikawa-Ichinose T; Kisu K; Sekimoto A; Saito R; Oe Y; Matsumoto Y; Tomioka Y; Mori T; Takahashi N; Sato H; Abe T; Niwa T; Ito S
    Toxins (Basel); 2017 Dec; 10(1):. PubMed ID: 29283413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein-bound uremic toxins: new culprits of cardiovascular events in chronic kidney disease patients.
    Ito S; Yoshida M
    Toxins (Basel); 2014 Feb; 6(2):665-78. PubMed ID: 24561478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of protein-bound uremic toxins indoxyl sulphate and p-cresyl sulphate in acute kidney injury.
    Veldeman L; Vanmassenhove J; Van Biesen W; Massy ZA; Liabeuf S; Glorieux G; Vanholder R
    Int Urol Nephrol; 2019 Feb; 51(2):293-302. PubMed ID: 30604232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved dialysis removal of protein-bound uremic toxins by salvianolic acids.
    Li J; Wang Y; Xu X; Cao W; Shen Z; Wang N; Leng J; Zou N; Shang E; Zhu Z; Guo J; Duan J
    Phytomedicine; 2019 Apr; 57():166-173. PubMed ID: 30772752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein-Bound Uremic Toxins and Immunity.
    Rocchetti MT; Cosola C; Ranieri E; Gesualdo L
    Methods Mol Biol; 2021; 2325():215-227. PubMed ID: 34053061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uraemic toxins and cardiovascular disease across the chronic kidney disease spectrum: an observational study.
    Rossi M; Campbell K; Johnson D; Stanton T; Pascoe E; Hawley C; Dimeski G; McWhinney B; Ungerer J; Isbel N
    Nutr Metab Cardiovasc Dis; 2014 Sep; 24(9):1035-42. PubMed ID: 24880738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-Analysis of the Associations of p-Cresyl Sulfate (PCS) and Indoxyl Sulfate (IS) with Cardiovascular Events and All-Cause Mortality in Patients with Chronic Renal Failure.
    Lin CJ; Wu V; Wu PC; Wu CJ
    PLoS One; 2015; 10(7):e0132589. PubMed ID: 26173073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms underlying uremic toxin-related systemic disorders in chronic kidney disease: focused on β
    Yamamoto S
    Clin Exp Nephrol; 2019 Feb; 23(2):151-157. PubMed ID: 29869756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-bound uremic toxins: new insight from clinical studies.
    Liabeuf S; Drüeke TB; Massy ZA
    Toxins (Basel); 2011 Jul; 3(7):911-9. PubMed ID: 22069747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of oral charcoal adsorbent (AST-120) suppresses low-turnover bone progression in uraemic rats.
    Iwasaki Y; Yamato H; Nii-Kono T; Fujieda A; Uchida M; Hosokawa A; Motojima M; Fukagawa M
    Nephrol Dial Transplant; 2006 Oct; 21(10):2768-74. PubMed ID: 16820376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.